32,723 Shares in LifeVantage Co. (NASDAQ:LFVN) Acquired by Millennium Management LLC

Millennium Management LLC bought a new position in LifeVantage Co. (NASDAQ:LFVN) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 32,723 shares of the company’s stock, valued at approximately $574,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in LFVN. Hillsdale Investment Management Inc. lifted its holdings in shares of LifeVantage by 7.3% during the fourth quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company’s stock worth $258,000 after buying an additional 1,000 shares during the last quarter. Barclays PLC lifted its holdings in shares of LifeVantage by 3.6% during the fourth quarter. Barclays PLC now owns 43,472 shares of the company’s stock worth $763,000 after buying an additional 1,506 shares during the last quarter. Northern Trust Corp lifted its holdings in shares of LifeVantage by 27.6% during the fourth quarter. Northern Trust Corp now owns 44,176 shares of the company’s stock worth $774,000 after buying an additional 9,552 shares during the last quarter. Schonfeld Strategic Advisors LLC acquired a new position in shares of LifeVantage during the fourth quarter worth approximately $282,000. Finally, Bank of New York Mellon Corp lifted its holdings in shares of LifeVantage by 43.9% during the fourth quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company’s stock worth $1,300,000 after buying an additional 22,620 shares during the last quarter. 35.32% of the stock is currently owned by institutional investors and hedge funds.

LifeVantage Trading Up 1.1%

LFVN opened at $12.52 on Monday. The stock has a market cap of $157.60 million, a PE ratio of 22.36 and a beta of 0.43. LifeVantage Co. has a 1 year low of $5.22 and a 1 year high of $27.38. The stock’s 50 day simple moving average is $13.04 and its 200-day simple moving average is $16.24.

LifeVantage (NASDAQ:LFVN) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.10. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%. The business had revenue of $58.44 million for the quarter, compared to analysts’ expectations of $60.99 million.

LifeVantage Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be issued a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a dividend yield of 1.44%. The ex-dividend date is Friday, May 30th. This is a boost from LifeVantage’s previous quarterly dividend of $0.04. LifeVantage’s dividend payout ratio is presently 26.09%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.